1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CCSER2 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA GSE1 CTRPv2 pan-cancer AAC -0.095 0.02
mRNA SETD2 CTRPv2 pan-cancer AAC -0.1 0.02
mRNA ZNF157 CTRPv2 pan-cancer AAC -0.095 0.02
mRNA PEX11G CTRPv2 pan-cancer AAC 0.096 0.02
mRNA C1D CTRPv2 pan-cancer AAC 0.091 0.02
mRNA ELAVL1 CTRPv2 pan-cancer AAC -0.098 0.02
mRNA CARMIL2 CTRPv2 pan-cancer AAC -0.12 0.02
mRNA PAIP2 CTRPv2 pan-cancer AAC -0.095 0.02
mRNA SENP1 CTRPv2 pan-cancer AAC -0.095 0.02
Download CSV